Condition: Head and Neck Cancer · Head and Neck Squamous Cell Carcinoma · Oropharynx Cancer · Sponsor: Medical University of South Carolina
The goal of this clinical trial is to compare the effectiveness of a navigation-based multilevel intervention (ENDURE) with treatment as usual (TAU) to improve the initiation of guideline-adherent postoperative radiation therapy among patients with head and neck cancer. The main questions the trial aims to answer are: 1. Does ENDURE improve initiation of timely PORT relative to treatment as usual? 2. What are the mechanisms through which ENDURE improves timeliness to treatment? 3. What are the barriers and facilitators to the implementation of ENDURE into routine clinical care?
This description comes directly from the study's public registry record.
Evan M Graboyes, MD, MPH · 843-792-0719 · graboyes@musc.edu
Always discuss trial participation with your own doctor first.
| Washington University in St. Louis | St Louis, Missouri, United States | Recruiting |
| Duke University Medical Center | Durham, North Carolina, United States | Recruiting |
| Medical University of South Carolina | Charleston, South Carolina, United States | Recruiting |
| Baylor College of Medicine | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05793151